About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Thrombosis Journal
›
top-articles
Thrombosis Journal
2.9
(top 20%)
impact factor
779
(top 20%)
papers
11.4K
(top 20%)
citations
50
(top 10%)
h
-index
3.0
(top 20%)
extended IF
794
all documents
12.3K
doc citations
78
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies
Thrombosis Journal
2013
471
2
Development of an in vitro model to study clot lysis activity of thrombolytic drugs
Thrombosis Journal
2006
223
3
Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases
Thrombosis Journal
2019
200
4
Hereditary thrombophilia
Thrombosis Journal
2006
189
5
A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysis
Thrombosis Journal
2015
171
6
Contact pathway of coagulation and inflammation
Thrombosis Journal
2015
156
7
Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications
Thrombosis Journal
2007
153
8
Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring
Thrombosis Journal
2013
141
9
Platelets and platelet adhesion molecules: novel mechanisms of thrombosis and anti-thrombotic therapies
Thrombosis Journal
2016
141
10
Laboratory assessment of rivaroxaban: a review
Thrombosis Journal
2013
134
11
Sepsis and septic shock: endothelial molecular pathogenesis associated with vascular microthrombotic disease
Thrombosis Journal
2019
133
12
Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis
Thrombosis Journal
2016
130
13
Towards a standardization of thrombin generation assessment: the influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assay
Thrombosis Journal
2005
112
14
Thrombosis in vasculitis: from pathogenesis to treatment
Thrombosis Journal
2015
112
15
Evaluation of the TEG platelet mapping assay in blood donors
Thrombosis Journal
2007
110
16
Heparin-induced thrombocytopenia: an update
Thrombosis Journal
2005
108
17
Thrombosis in inflammatory bowel diseases: what’s the link?
Thrombosis Journal
2015
99
18
The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis in hospitalized cirrhotic patients
Thrombosis Journal
2011
94
19
Perioperative management of patients on direct oral anticoagulants
Thrombosis Journal
2017
92
20
Circulating microRNA-126 in patients with coronary artery disease: correlation with LDL cholesterol
Thrombosis Journal
2012
90
21
Hypothermia: effects on platelet function and hemostasis
Thrombosis Journal
2014
90
22
Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program
Thrombosis Journal
2015
90
23
The antithrombotic profile of aspirin. Aspirin resistance, or simply failure?
Thrombosis Journal
2004
89
24
Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories
Thrombosis Journal
2016
88
25
Blood coagulation and the risk of atherothrombosis: a complex relationship
Thrombosis Journal
2004
86
26
Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression
Thrombosis Journal
2014
86
27
Association between plasminogen activator inhibitor-1 and cardiovascular events: a systematic review and meta-analysis
Thrombosis Journal
2018
83
28
Venous thromboembolism in the elderly: efficacy and safety of non-VKA oral anticoagulants
Thrombosis Journal
2014
78
29
Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels
Thrombosis Journal
2005
77
30
Efficacy and safety of edoxaban versus enoxaparin for the prevention of venous thromboembolism following total hip arthroplasty: STARS J-V
Thrombosis Journal
2015
77
31
Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis
Thrombosis Journal
2020
76
32
Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy
Thrombosis Journal
2018
75
33
Global assays of hemostasis in the diagnostics of hypercoagulation and evaluation of thrombosis risk
Thrombosis Journal
2015
70
34
DOACs – advances and limitations in real world
Thrombosis Journal
2016
69
35
Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity
Thrombosis Journal
2016
67
36
The diagnosis and treatment of venous thromboembolism in Asian patients
Thrombosis Journal
2018
65
37
Human blood platelets and viruses: defense mechanism and role in the removal of viral pathogens
Thrombosis Journal
2018
64
38
Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective study
Thrombosis Journal
2018
63
39
Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation
Thrombosis Journal
2006
62
40
Circulating histone H3 levels in septic patients are associated with coagulopathy, multiple organ failure, and death: a single-center observational study
Thrombosis Journal
2019
62
41
Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
Thrombosis Journal
2004
59
42
Assays of different aspects of haemostasis – what do they measure?
Thrombosis Journal
2015
59
43
Resolution of left atrial appendage thrombus with apixaban
Thrombosis Journal
2013
58
44
Causes of venous thrombosis
Thrombosis Journal
2016
57
45
New oral anticoagulants: discussion on monitoring and adherence should start now!
Thrombosis Journal
2013
56
46
TEG® and RapidTEG® are unreliable for detecting warfarin-coagulopathy: a prospective cohort study
Thrombosis Journal
2014
56
47
Systemic lupus erythematosus and thrombosis
Thrombosis Journal
2015
56
48
Predictive risk factors of venous thromboembolism (VTE) associated with peripherally inserted central catheters (PICC) in ambulant solid cancer patients: retrospective single Centre cohort study
Thrombosis Journal
2019
56
49
Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairment
Thrombosis Journal
2014
55
50
NOACs replace VKA as preferred oral anticoagulant among new patients: a drug utilization study in 560 pharmacies in The Netherlands
Thrombosis Journal
2018
55
site/software ©
exaly
; All materials licenced under
CC by-SA
.